Global Fertility Services Market Assessment, By Procedure [In-vitro Fertilization with Intracytoplasmic Sperm Injection, Intrauterine Insemination, In-vitro Fertilization without Intracytoplasmic Sperm Injection, Surrogacy, Others], By Service [Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor, Frozen Donor], By Cause of Infertility [Male Infertility, Female Infertility], By Provider [Fertility Clinics, Hospitals, Others], By Region, Opportunities and Forecast, 2018-2032F

Global fertility services market is projected to witness a CAGR of 8.92% during the forecast period 2025-2032, growing from USD 39.31 billion in 2024 to USD 77.86 billion in 2032. The rising cases of infertility, the introduction of favorable policies and initiatives, increasing awareness and acceptance of fertility treatments, and growing emphasis on introducing new technologies are some of the major factors supporting the market’s expansion.

The growing efforts of healthcare organizations to bolster the availability of advanced fertility services across the globe are also propelling the market's growth. Countries are increasingly investing in state-of-the-art facilities to provide personalized treatments and address the rising requirement for fertility treatments. For instance, in October 2024, Burjeel Holdings launched the Trust Fertility Clinic at their flagship facility, Burjeel Medical City (BMC), to support patients suffering from fertility issues by providing them with personalized and compassionate care. The clinic offers a comprehensive range of fertility services along with integrated and holistic healthcare services for women at different stages of life. The clinic is equipped with advanced technologies such as artificial intelligence (AI)- driven embryo selection, ensuring enhanced treatment outcomes. The availability of such technologies is expected to provide lucrative growth opportunities for the market as well as improve medical tourism in the Middle East.

Countries with declining population growth are introducing various policies and initiatives to support population growth. The Tokyo Metropolitan Government plans on implementing a four-day workweek starting in April 2025, to improve workplace flexibility and allow the population to balance family responsibilities. Such measures are being introduced to reverse the population crisis and improve the country’s birth rate. The number of births in Japan fell under 700,000 for the first time in 2024. The four-day workweek policy is expected to allow the population to focus on raising a family without having to compromise on career growth. Such measures are expected to encourage the population to focus on family planning and provide lucrative growth opportunities for the market. 

Rising Government Initiatives Support Market Expansion

The introduction of supportive government policies and initiatives is significantly driving the growth of the market as it aids in improving affordability, accessibility, and awareness about the different fertility treatments available. Various governments are investing significantly in ensuring the availability of fertility services for a broader population group and proposing new tax credits to cover the costs of the treatment. For instance, in October 2024, the government of Ontario added USD 150 million to the Ontario Fertility Program to bolster access to fertility treatments over the course of the next two years. The additional funding is going to support the expansion of fertility clinics, ensuring reduced waiting periods in community centers and hospitals. The program will also include more clinics, providing more options to the patient population and increasing the ease of access to key fertility services. The government also proposed a new tax credit that would cover up to 25% of all eligible expenses, including travel for treatment and diagnostic testing, fertility medications, and IVF cycles. Such efforts are expected to bolster the demand for different fertility services and provide lucrative growth opportunities for the market.

Technological Advancements Drive Market Growth

The growing efforts of leading market players to ensure the availability of advanced technologies is one of the major drivers of the global fertility services market. Innovations such as minimally invasive egg retrieval, along with the integration of genetic screening and personalized treatment plans, are increasing patient acceptance and adoption and improving treatment outcomes. Hospitals and clinics across the globe are also ensuring the availability of novel technologies to enhance patient comfort and convenience. For instance, in February 2025, Corniche Hospital successfully performed a minimally invasive laparoscopic procedure for collecting and freezing eggs. The successful completion of the procedure is going to ensure that women who are unable to rely on traditional fertility preservation services can receive effective fertility preservation solutions. The efficient and safe nature of laparoscopic egg retrieval is also ensuring that women facing various social and medical challenges also have access to fertility services.

Rapid advancements in cryopreservation techniques also support the market’s expansion by allowing a broader population group to preserve their genetic material for future utilization. Such advancements are augmenting the efficiency of fertility services and allowing hospitals and clinics to attract more patients, thus bolstering the market’s growth.

Fertility Clinics Account for Significant Share of the Market

Fertility clinics account for a significant share of the market as they specialize in identifying the cause of infertility and providing suitable treatment options and supportive services. These clinics are usually run by reproductive endocrinologists with training in reproductive medicine and offer a wide range of services such as semen analysis, genetic screening, hormone testing, in-vitro fertilization (IVF), tubal ligation reversal, and egg freezing. These clinics also provide personalized treatments tailored to the specific requirements of the patient population.

Additionally, the growing efforts to bolster the availability of fertility services in underserved locations are also supporting the segment’s expansion. In February 2025, Wellnest Fertility Inc. opened a Wellnest Fertility Clinic in Utah, United States. The state-of-the-art clinic offers comprehensive fertility solutions and provides personalized treatment plans and cutting-edge embryo monitoring technology, removing geographical barriers and allowing patients to receive high-quality fertility care. The introduction of continuous embryo monitoring technology gives embryologists various necessary insights, ultimately improving patient outcomes. The increasing availability of such facilities and services by fertility clinics across the globe is expected to bolster patient confidence in fertility services and treatment, providing lucrative growth opportunities for the market. 

North America Region Holds Major Market Share

The rising requirement for advanced reproductive technologies can be attributed to increasing cases of infertility, rising awareness about the various treatment options available, reduced stigma about fertility services, and the introduction of supportive government policies and initiatives. Due to the presence of the required infrastructure, advanced technologies such as in-vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI), intrauterine insemination (IUI), and in-vitro fertilization without intracytoplasmic sperm injection (IVF without ICSI) are also easily available in the region. Such services offer high success rates, increasing confidence among the patient population, thus boosting the market’s demand.

Additionally, growing efforts to expand fertility centers in the region support the market’s expansion. For instance, in February 2025, Reproductive Partners Fertility Center- San Diego announced the expansion of their fertility care team to meet the growing demand for fertility services in the region. Through this expansion, the fertility center aims to provide a wide range of treatments for recurrent miscarriages, unexplained infertility, and diminished ovarian reserve. Such expansions showcase the rising requirement for fertility services and growing emphasis on the provision of high-quality care for patients.

Download Free Sample Report

Future Market Scenario (2025-2032F)

• As per the global fertility services market analysis, the market is expected to grow significantly over the forecast period due to rising government initiatives to boost population growth, technological advancements, and increasing infertility rates in various regions. Various countries are introducing fertility-friendly policies, including financial assistance programs and insurance coverage for treatment procedures.
• As more and more patients seek non-invasive treatments due to physical discomfort associated with fertility procedures, the demand for minimally invasive fertility treatments is expected to rise significantly over the coming years.
• Factors such as increasing investments in fertility research, evolving societal attitudes towards fertility treatment, and the growing popularity of medical tourism are expected to support the market’s expansion.
• Rapid advancements in cryopreservation techniques due to increasing requirement for donation and storage of biological materials are expected to bolster the accessibility of fertility treatments for couples suffering from infertility. The World Health Organization (WHO) estimates that 1 in 6 adults across the globe experience infertility during their lifetime.

Report Scope

“Fertility Services Market Assessment, Opportunities and Forecast, 2018-2032F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global fertility services market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2025 and 2032. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Report Attribute	Details
Base Year of the Analysis	2024
Historical Period	2018-2023
Forecast Period	2025-2032
Projected Growth Rate	CAGR of 8.92% between 2025 and 2032
Revenue Forecast in 2032	USD 77.86 billion
Segments Covered	Procedure, Cause of Infertility, Service, Provider
Regions Covered	North America, Europe, South America, Asia-Pacific, Middle East and Africa
Key Companies Profile	IVIRMA Global SL, Apollo Hospitals Group, Genea Pty Limited, Monash IVF Group, CRGH City, Virtus Health Group, OvaScience, Inc., Weill Cornell Medicine, Progyny, Inc., Carolinas Fertility Institute
Customization Scope	15% free report customization with purchase
Pricing and Purchase Options	Avail the customized purchase options to fulfill your precise research needs
Delivery Format	PDF and Excel through email (subject to the license purchased)

In the report, global fertility services market has been segmented into the following categories: 

• By Procedure
  • In-vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
  • Intrauterine Insemination (IUI)
  • In-vitro Fertilization without Intracytoplasmic Sperm Injection (IVF without ICSI)
  • Surrogacy
  • Others
• By Service
  • Fresh Non-Donor
  • Frozen Non-Donor
  • Egg and Embryo Banking
  • Fresh Donor
  • Frozen Donor
• By Cause of Infertility
  • Male Infertility
  • Female Infertility
• By Provider
  • Fertility Clinics
  • Hospitals
  • Others
• By Region
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Key Players Landscape and Outlook

The leading players across the globe are focusing on expanding their presence and ensuring the availability of advanced services for the patient population. In order to do so, they are actively engaging in mergers and acquisitions along with partnerships with other fertility service providers. For instance, in October 2024, Ivy Fertility Services, LLC acquired Northern California Fertility Medical Center. This acquisition aligns with the global trend of consolidation in the fertility services sector, allowing larger networks to offer a broad range of services and innovative treatments. The companies are also going to expand their unified presence, making it easier for patients to access various fertility services and treatment options.

Key Players Operating in the Global Fertility Services Market are:

• IVIRMA Global SL
• Apollo Hospitals Group
• Genea Pty Limited
• Monash IVF Group
• CRGH City
• Virtus Health Group
• OvaScience, Inc.
• Weill Cornell Medicine
• Progyny, Inc.
• Carolinas Fertility Institute

Markets and Data’s reports answer the following questions:

• What is the current and future market size of the product/service in question globally or specific to different countries?
• How are the markets divided into different product/service segments and the market size and growth of each segment?
• What is the market potential of different product segments and their investment case?
• How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
• What is the business environment and regulatory landscape specific to the product/service?

If you can't find what you're searching for or have any custom requirements for global fertility services market, you may approach our team at info@marketsandata.com.